C apsular contracture associated with fibroproliferation is the main complication in postmastectomy tissue expander and implant breast reconstruction in patients requiring radiotherapy, 1 but the pathogenesis of radiotherapy-induced capsular contracture is unknown. Strategies that have been suggested for prevention of radiation-induced injury in other tissues are either ineffective [2] [3] [4] [5] or untested 6, 7 in capsular contracture. We believe that if the pathogenic mechanism is elucidated, strategies can be developed to mitigate the effects of radiation-induced capsular contracture.
The canonical wingless signaling pathway has been demonstrated in the pathogenesis of fibroproliferation in fibromatosis, 8, 9 Dupuytren's disease (palmar fibromatosis), 10, 11 and hyperplastic skin wounds. 12, 13 Clinically, fibrosis is a key char-acteristic of implant capsules that have undergone contracture following radiotherapy. The wingless signaling pathway has been reviewed recently 14 and is illustrated in Figure 1 . In normal resting cells without wingless signaling, ␤-catenin is phosphorylated by a protein complex including adenomatous polyposis coli, axin, and glycogen synthase kinase-3␤ (GSK-3␤). The phosphorylated ␤-catenin undergoes ubiquitin-mediated degradation. When the frizzled receptor is activated by a wingless ligand, the disheveled protein is phosphorylated to inhibit the action of the protein complex mainly by phosphorylation (inhibition) of GSK-3␤. The protein complex is no longer able to degrade ␤-catenin by phosphorylation. The nonphosphorylated ␤-catenin is now free, and it migrates to the nucleus to bind with T cell-specific factor protein to form a transcription factor complex, resulting in up-regulation of target genes such as the cyclooxygenase-2 (COX-2) gene, increase in synthesis/release of prostaglandin E 2 , and fibroproliferation. 15, 16 Radiation-induced fibrosis is well documented in human skin and capsular tissue around expanders and implants in breast reconstruction, 11, [17] [18] [19] [20] [21] but the pathogenesis is unknown. There is evidence, however, to indicate that the transforming growth factor-␤1 activates the downstream ␤-catenin in fibroblasts. 22 Furthermore, there is evidence to indicate that transforming growth factor-␤1 interacts with the wingless signaling pathways 23, 24 and that it also plays a central role in fibrosis. 7, 25, 26 Therefore, we hypothesized that the wingless signaling pathway (Fig. 1) is also involved in the pathogenesis of fibroproliferation, resulting in capsular contracture in postradiotherapy breast reconstruction with tissue expanders and implants. The aim of this study was to test our hypothesis by demonstrating that radiotherapy activates the wingless signal transduction pathway in the periprosthetic capsular tissue as indicated by the following events: phosphorylation of GSK-3␤ kinase, increase in cytoplasmic ␤-catenin protein expression, nucleus translocation of ␤-catenin, up-regulation of protein expression of COX-2, and up-regulation of collagen types I and III protein expression.
PATIENTS AND METHODS

Tissue Samples
Under an institutional review board-approved protocol, capsular tissue was obtained from postmastectomy patients undergoing second-stage breast reconstruction surgery to exchange a temporary tissue expander for a permanent breast implant. Biopsy specimens (1 ϫ 1 cm) of capsular tissue surrounding the expander were obtained from patients (n ϭ 5) who had bilateral mastectomies in which one side had prior radiotherapy and the other side had no radiotherapy. Prior radiotherapy had consisted of whole breast radiation delivered in a fractionated protocol to 50 Gy. Clinically, in all patients, the radiated side was firmer than the nonradiated side with the tissue expander in situ, corresponding to a Baker grade 2 capsular contracture. Biopsy specimens of capsule tissue were snap-frozen in liquid nitrogen to be stored at Ϫ80°C for Western blot analysis. In addition, one 0.2 ϫ 0.2-cm sample of radiated and nonradiated capsular tissue was obtained and preserved in sodium phosphate buffer with 10% formalin (pH 7.4) for immunohistochemistry study.
Western Blot Assays
Frozen capsule samples were homogenized at 4°C in a lysis buffer (100 mg/ml). 27 Supernatants obtained after centrifugation at 14,000 g and 4°C for 20 minutes were used for determination of protein content using the Bio-Rad DC assay kit (Bio-Rad, Hercules, Calif.). Protein expression was determined. Briefly, after addition of Laemmli buffer to the aliquots of supernatants (50 to 100 
Plastic and Reconstructive Surgery • February 2010
g of total protein) to a final concentration of 50%, the samples were denatured by 2 minutes of boiling and resolved by electrophoresis on 8% to 10% sodium dodecyl sulfate polyacrylamide gel. The separated proteins were electrophorectically transferred at 4°C to polyvinyliden difluoride membranes at a constant voltage (35 V) overnight. The blots were incubated for 1 hour at room temperature in Tris-buffered saline with 0.1% Tween 20 (TBST) and 1% bovine serum albumin to block nonspecific antibody binding. All the blots were incubated for 1 hour at room temperature with an antibody to one of the following proteins: ␤-catenin, collagen type I, collagen type III, COX-2, GSK-3␤, or phosphoserine-9-GSK-3␤. Blots were then washed three times (5 minutes each) in TBST and incubated for 1 hour at room temperature with horseradish peroxidase-conjugated anti-mouse or antirabbit immunoglobulin G secondary antibody. The blots were washed six more times with TBST and developed by the enhanced chemiluminescence reagent (PerkinElmer, Waltham, Mass.) on high-performance chemiluminescence film (Amersham Life Science, Bukinghamshire, United Kingdom). The band density was quantified using scanning laser densitometry (Flurochem software; Alpha Innotec, San Leandro, Calif.). The Western blots were probed with ␤-actin antibody for standardization of protein loading. Mouse macrophage lysate served as negative control for ␤-catenin, and Hela cell lysate served as positive control.
Antibodies for ␤-catenin and COX-2 were purchased from BD-Transduction Laboratories (Lexington, N.Y.), those for collagen types I and III were from Abcam Inc. (Cambridge, Mass.), and those for GSK-3␤ and phospho-serine-9-GSK-3␤ were from Cell Signaling (Denvers, Mass.). Monocolonal anti-␤-actin was purchased from Sigma (Oakville, Ontario, Canada).
Immunohistochemistry for ␤-Catenin
Periprosthetic capsule tissue (radiated and nonradiated) was fixed overnight in 10% formalin and embedded in paraffin. Sections of 5 m were dewaxed, and endogenous peroxidase was quenched by treatment with 3% hydrogen peroxide in methanol for 15 minutes. Sections were washed with phosphate-buffered saline, subjected to heat-induced epitope retrieval in 10 mM citrate buffer (pH 6.0), and blocked with avidin/biotin and normal rabbit serum. The sections were incubated overnight at 4°C with goat anti-␤-catenin antibody (Santa Cruz Biotechnology, Santa Cruz, Calif.) diluted 1/200 in rabbit serum. A biotinylated rabbit anti-goat immunoglobulin G (Vector Laboratories, Burlington, Ontario, Canada) diluted 1/200 was used to detect the primary antibody. Immunodetection was performed using the Elite Vector Stain ABC System (Vector Laboratories). Color visualization was performed using 3-3=-diaminobenzidine as the chromagen substrate. Sections were counterstained with hematoxylin and coverslipped using permamount. The slides were scanned using the Zeiss Mirax Scan (Carl Zeiss, Inc., Oberkochen, Germany).
Data Analysis
Quantified band density for each Western blot (representative of three or five biopsies) was expressed as mean Ϯ SEM. Wilcoxon signed rank test was used to assess significance of paired data, using the Graph Pad Version 2 program (Graph Pad Software Inc., San Diego, Calif.). A value of p less than or equal to 0.05 was considered statistically significant. Qualitative analysis of immunostained radiated and nonradiated capsular tissue samples was used to detect evidence of ␤-catenin nuclear translocation.
RESULTS
Western blot analyses demonstrating increased protein expression of phospho-serine-9-GSK-3␤ and total GSK-3␤ in radiated compared with nonradiated capsular tissue biopsies from three patients are shown in Figure 2 . This is shown quantitatively in Figure 3 using scanning units of the target protein as a ratio of ␤-actin scanning units for each tissue sample. Protein expression of phospho-GSK-3␤ and GSK-3␤ were significantly (p Ͻ 0.01; n ϭ 3 patients) increased in the radiated capsule compared with the nonradiated capsule, with phospho-serine-9-GSK-3␤ being increased 6.7-fold and total GSK-3␤ being increased 3.0-fold (Fig. 4) . Only three of five biopsy specimens were large enough to provide tissue to do these two assays.
Representative Western blot analyses are shown in Figure 5 that depict increased protein expression of ␤-catenin, COX-2, collagen type I, and collagen type III. Quantitative evaluation for all biopsy specimens from five patients is shown in Figures 6 and 7 . Significant (p Ͻ 0.01; n ϭ 5 patients) increases in protein expression are shown in Figure 8 , with the following increases in radiated versus nonradiated capsular tissue: ␤-catenin, 2.3-fold; COX-2, 2.8-Volume 125, Number 2 • Radiation-Induced Capsular Contracture Fig. 2 . Western blot analyses for phospho-serine-9-GSK-3␤, total GSK-3␤, and ␤-actin (protein-loading control) in human capsular tissue biopsy specimens obtained from three patients with bilateral mastectomies with radiation (R) on one side and no radiation (NR) on the other side. fold; collagen type I, 1.6-fold; and collagen type III, 1.8-fold.
Formalin-fixed, paraffin-embedded capsular tissue samples processed with ␤-catenin immunostaining and hematoxylin counterstain are shown in Figure 9 . In nonradiated tissue, ␤-catenin stained faintly and diffusely in the fibroblast cytoplasm and in occasional endothelial cells of Volume 125, Number 2 • Radiation-Induced Capsular Contracture the vascular channels. In contrast, the radiated tissue demonstrates localized and more intense staining in fibroblasts, consistent with a nuclear pattern of staining. Incidental note is also made of increased density of vascular channels and collagen fibers with routine hematoxylin staining.
DISCUSSION
As a result of earlier detection and improved treatments, such as surgery, hormonal therapies, chemotherapy, and radiotherapy, the mortality rate for breast cancer patients is at its lowest since the 1950s. Therefore, more breast cancer patients are surviving to live with the sequelae of their treatment. Postmastectomy breast reconstruction is recognized as an integral part of breast cancer survivorship. Complications with resultant poor outcomes may occur, however, with tissue expander and implant breast reconstruction in patients requiring radiotherapy. The main complication is fibroproliferation of the capsular tissue around the expander with resultant capsular contracture. This leads to poor expansion and breast distortion with poor aesthetic outcome and pain, and often requires additional surgery. At the present time, the pathogenic mechanism of radiation-induced fibroproliferation and capsular contracture is unknown.
According to the wingless signaling pathway in Figure 1 , the frizzled receptors are activated in the presence of wingless ligands, and these receptors phosphorylate the disheveled protein, which in turn inhibits GSK-3␤ by phosphorylation. The phosphorylated GSK-3␤ is unable to phosphorylate downstream ␤-catenin. The nonphosphorylated free ␤-catenin translocates to the nucleus to bind with T cell-specific factor protein to form a transcript factor complex to up-regulate cox-2 gene, resulting in an increase in fibroproliferation. Findings obtained from the present study support our hypothesis of the involvement of the wingless signaling pathway in radiation-induced capsular fibroproliferation, and the clinical entity of capsular contracture. Specifically, the following protein contents were significantly (p Ͻ 0.01) increased in the radiated capsule compared with the nonradiated capsule: phospho-GSK-3␤ (6.7-fold), total GSK-3␤ (3.0-fold), ␤-catenin (2.3-fold), COX-2 (2.8-fold), collagen type I (1.6-fold), and collagen type III (1.8-fold). These increases in protein expression are shown in Figures 4 and 8 . Furthermore, immunohistochemical staining also showed that there was increased fibroblast cytosolic ␤-catenin present and evidence of ␤-catenin nuclear translocation in radiated compared with nonradiated capsular tissue (Fig. 9 ).
An understanding of the pathogenesis of the fibroproliferative process that occurs with tissue Volume 125, Number 2 • Radiation-Induced Capsular Contracture expansion in tissues previously treated with radiotherapy will most likely lead to discovery of prevention or treatment strategies clinically. For example, selective COX-2 inhibitors are commercially available and have been shown to partially decrease cell proliferation in models of fibromatosis that are mediated by increased levels of ␤-catenin.
14 There is a great potential to explore treatment protocols in an animal model and eventually in clinical trials.
CONCLUSIONS
Recent experimental evidence has shown that the wingless signaling pathway plays an important role in the pathogenesis of fibroproliferative disorders, such as fibromatosis and hyperplastic skin wounds. It involves multiple linked events leading to up-regulation of target genes and fibroproliferation. We hypothesized that the wingless signaling pathway is also responsible for regulating fibroproliferation in capsular tissue around expanders and implants that have been placed a previously irradiated field. The findings in the present study are consistent with expected changes that would occur with activation of this signaling pathway in the radiated capsular tissue samples. This study provides supporting evidence that the wingless signaling pathway is involved in the pathogenesis of radiation-induced fibroproliferation and capsular contracture. Further studies are required to use this information to develop therapeutic treatment strategies to attenuate fibroproliferation in radiated capsular tissue. 
